Skip to main content
Click to view our COVID protocols

To Our Valued Patients,

With the evolving situation of the Coronavirus (COVID-19) pandemic and under the guidelines of the Health Officer of the Alameda and Contra-Costa Counties, our offices are open to provide eye and vision care.

Please keep in mind that in order to maintain social distancing protocols and to limit further transmission of the virus, we will be working with a reduced staff and seeing a fewer number of patients as compared to our “normal” schedule. Priority will be given to the most urgent medical cases. We will be implementing a number of measures (including altered check-in/check-out procedures, limiting the number of patients in the office and waiting room, face covering for all persons, temperature screening, etc) that will change your experience in the office. In addition, we will be ramping up our already strict disinfection policies and we will continue to monitor and abide by all local, state and, federal guidelines. Please bear with us through this new reality as these changes are designed to protect you and our staff.

We hope to see you soon and appreciate your trust in us to continue to meet your eye care needs. Stay safe and stay healthy!

The Turner Eye Institute Team

Home » What's New » Information on Fusarium Keratitis for KFAX listeners

Information on Fusarium Keratitis for KFAX listeners

Latest case numbers

From the U.S. Centers for Disease Control and Prevention (CDC):

  • 106 confirmed cases of Fusarium keratitis
  • 12 “possible” cases and 80 still under investigation
  • Confirmed cases or cases under investigation reported in 32 states or territories (see list below).

What products were used in Fusarium keratitis cases (from the CDC, May 9):

  • Complete data are available on 98 confirmed. Of those 98, 93 (95 percent) were listed as a contact lens user.
  • The products reported used in those 93:
    • 59 (66 percent) – Bausch & Lomb ReNu with MoistureLoc
    • 19 (21 percent) - Bausch & Lomb ReNu MultiPlus
    • 9 (10 percent) – Bausch & Lomb ReNu (unspecified)
    • 3 (3 percent) - any Advanced Medical Optics (AMO) product
    • 4 (4 percent) – any Alcon product

Helpful links:
American Academy of Ophthalmology Web Site

US Food and Drug Administration Web Site

Centers for Disease Control and Prevention Web Site

Bausch and Lomb Company Web Site